Page 46 - ITPS-7-2

INNOSC Theranostics and
Pharmacological Sciences Mitochondria and aging

Cell Metab. 2011;14(5):623-634. 246. Luna-Sánchez M, Bianchi P, Quintana A. Mitochondria-
induced immune response as a trigger for
doi: 10.1016/j.cmet.2011.09.013
neurodegeneration: A pathogen from within. Int J Mol Sci.
236. Laker RC, Drake JC, Wilson RJ, et al. Ampk phosphorylation 2021;22(16):8523.
of Ulk1 is required for targeting of mitochondria to
lysosomes in exercise-induced mitophagy. Nat Commun. doi: 10.3390/ijms22168523
2017;8(1):548. 247. Zhang Q, Raoof M, Chen Y, et al. Circulating mitochondrial
DAMPs cause inflammatory responses to injury. Nature.
doi: 10.1038/s41467-017-00520-9
2010;464(7285):104-107.
237. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin
gene cause autosomal recessive juvenile parkinsonism. doi: 10.1038/nature08780
Nature. 1998;392(6676):605-608. 248. Collins LV, Hajizadeh S, Holme E, Jonsson IM, Tarkowski A.
Endogenously oxidized mitochondrial DNA induces
doi: 10.1038/33416
in vivo and in vitro inflammatory responses. J Leukoc Biol.
238. Valente EM, Abou-Sleiman PM, Caputo V, et al. Hereditary 2004;75(6):995-1000.
early-onset Parkinson’s disease caused by mutations in
PINK1. Science. 2004;304(5674):1158-1160. doi: 10.1189/jlb.0703328
249. Wu J, Sun L, Chen X, et al. Cyclic GMP-AMP is an
doi: 10.1126/science.1096284
endogenous second messenger in innate immune signaling
239. Wilhelmus MMM, van der Pol SMA, Jansen Q, et al. by cytosolic DNA. Science. 2013;339(6121):826-830.
Association of Parkinson disease-related protein PINK1
with Alzheimer disease and multiple sclerosis brain lesions. doi: 10.1126/science.1229963
Free Radic Biol Med. 2011;50(3):469-476. 250. Oka T, Hikoso S, Yamaguchi O, et al. Mitochondrial DNA
that escapes from autophagy causes inflammation and
doi: 10.1016/j.freeradbiomed.2010.11.033
heart failure. Nature. 2012;485(7397):251-255.
240. Witte ME, Bol JG, Gerritsen WH, et al. Parkinson’s
disease-associated parkin colocalizes with Alzheimer’s doi: 10.1038/nature10992
disease and multiple sclerosis brain lesions. Neurobiol Dis. 251. Shimada K, Crother TR, Karlin J, et al. Oxidized
2009;36(3):445-452. mitochondrial DNA activates the NLRP3 inflammasome
during apoptosis. Immunity. 2012;36(3):401-414.
doi: 10.1016/j.nbd.2009.08.009
doi: 10.1016/j.immuni.2012.01.009
241. Cummins N, Tweedie A, Zuryn S, Bertran‐Gonzalez J,
Götz J. Disease‐associated tau impairs mitophagy by 252. Youm YH, Grant RW, McCabe LR, et al. Canonical Nlrp3
inhibiting Parkin translocation to mitochondria. EMBO inflammasome links systemic low-grade inflammation to
J. 2019;38(3):e99360. functional decline in aging. Cell Metab. 2013;18(4):519-532.
doi: 10.15252/embj.201899360 doi: 10.1016/j.cmet.2013.09.010
242. Ryan TA, Tumbarello DA. A central role for mitochondrial- 253. Pinti M, Cevenini E, Nasi M, et al. Circulating mitochondrial
derived vesicles in the innate immune response: DNA increases with age and is a familiar trait: Implications
Implications for Parkinson’s disease. Neural Regeneration for “inflamm‐aging”. Eur J Immunol. 2014;44(5):1552-1562.
Res. 2021;16(9):1779.
doi: 10.1002/eji.201343921
doi: 10.4103/1673-5374.306074
254. Trumpff C, Michelson J, Lagranha CJ, et al. Stress and
243. Twig G, Hyde B, Shirihai OS. Mitochondrial fusion, fission circulating cell-free mitochondrial DNA: A systematic
and autophagy as a quality control axis: The bioenergetic review of human studies, physiological considerations,
view. Biochim Biophys Acta. 2008;1777(9):1092-1097. and technical recommendations. Mitochondrion.
2021;59:225-245.
doi: 10.1016/j.bbabio.2008.05.001
doi: 10.1016/j.mito.2021.04.002
244. Chistiakov DA, Sobenin IA, Revin VV, Orekhov AN,
Bobryshev YV. Mitochondrial aging and age- 255. Logan DC. The mitochondrial compartment. J Exp Bot.
related dysfunction of mitochondria. Biomed Res Int. 2006;57(6):1225-1243.
2014;2014:238463.
doi: 10.1093/jxb/erj151
doi: 10.1155/2014/238463
256. Buchke S, Sharma M, Bora A, Relekar M, Bhanu P,
245. Nakahira K, Hisata S, Choi AMK. The roles of mitochondrial Kumar JJL. Mitochondria-targeted, nanoparticle-based
damage-associated molecular patterns in diseases. Antioxid drug-delivery systems: Therapeutics for mitochondrial
Redox Signal. 2015;23(17):1329-1350. disorders. Life (Basel). 2022;12(5):657.
doi: 10.1089/ars.2015.6407 doi: 10.3390/life12050657

Volume 7 Issue 2 (2024) 24 doi: 10.36922/itps.1726